Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-02-03T00:23:14.371Z Has data issue: false hasContentIssue false
  • English
  • Français

Detection of Cognitive Impairment and Dementia Using the Animal Fluency Test: The DECIDE Study

Published online by Cambridge University Press:  02 December 2014

Rolf Sebaldt ,
William Dalziel ,
Fadi Massoud ,
André Tanguay ,
Rick Ward ,
Lehana Thabane ,
Peter Melnyk ,
Pierre-Alexandre Landry  and
Benedicte Lescrauwaet
Rolf Sebaldt
Affiliation:
McMaster University, Hamilton
William Dalziel
Affiliation:
University of Ottawa, Ottawa, ON
Fadi Massoud
Affiliation:
Université de Montréal, Montréal
André Tanguay
Affiliation:
Centre Régional Ambulatoire de Laval, Laval
Rick Ward
Affiliation:
University of Calgary, Calgary, AB, Canada
Lehana Thabane
Affiliation:
McMaster University, Hamilton
Peter Melnyk
Affiliation:
BioMedCom Consultants Inc., Dorval
Pierre-Alexandre Landry*
Affiliation:
Pfizer Canada Inc., Kirkland
Benedicte Lescrauwaet
Affiliation:
Employed by Pfizer Canada Inc., Kirkland, QC
*
Pfizer Canada Inc., 17300 TransCanada Highway, Kirkland, Quebec, H9J 2M5, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives:

To evaluate the performance of a one-minute screening test measured against a validated 10-minute screening test for mild cognitive impairment (MCI) in detecting CI in patients aged ≥ 65 years with two or more vascular risk factors (VRF).

Methods:

Patients (n=1523) aged 65 years or older without documented CI symptoms or dementia with two or more VRF participated in this study set in Canadian primary care practice. Baseline data was collected, followed by the 1-minute animal fluency (AF) test and the 10-minute Montreal Cognitive Assessment (MoCA). Physicians (n=122) completed case reports during patient interviews and reported their diagnostic impression. AF test sensitivity, specificity, and accuracy in predicting a positive MoCA was assessed.

Results:

Study sample mean age was 79.7 years, 55% were female, 97.6% were Caucasian and 75% had ≤ 12 years of education. The AF test and MoCA detected CI in 52 and 56 percent of the study population, respectively. The AF test demonstrated sensitivity, specificity, and accuracy in predicting a positive MoCA of 67 percent each. Physicians diagnostic impression of MCI was reported for 37% of patients, and of dementia for 6%.

Conclusion:

In an elderly population with at least two VRF, using AF can be useful in detecting previously unknown symptoms of CI or dementia. Screening for CI in this high risk population is warranted to assist physician recognition of early CI. The short AF administration time favours its incorporation into clinical practice.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 5 , September 2009 , pp. 599 - 604
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1.Brayne, C, Gao, L, Dewey, M, Matthews, FE.Dementia before death in ageing societies-the promise of prevention and the reality. PLoS Med. 2006;3(10):e397.Google Scholar
2.Jorm, AF, Korten, AE, Henderson, AS.The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand. 1987;76(5):465–79.Google Scholar
3.The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group. Neurology. 2000;55(1):66–73.Google Scholar
4.Roman, GC.Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology. 2003;22(3):161–4.Google Scholar
5.Grossman, H, Bergmann, C, Parker, S.Dementia: a brief review. Mt Sinai J Med. 2006;73(7):985–92.Google ScholarPubMed
6.Martinez-Vila, E, Murie-Fernandez, M, Gallego Perez-Larraya, J, Irimia, P.Neuroprotection in vascular dementia. Cerebrovasc Dis. 2006;21 Suppl 2:106–17.Google Scholar
7.Brayne, C, Gill, C, Huppert, FA, Barkley, C, Gehlhaar, E, Girling, DM, et al.Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9(3):175–80.Google Scholar
8.Knopman, D, Boland, LL, Mosley, T, Howard, G, Liao, D, Szklo, M, et al.Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56(1):42–8.Google Scholar
9.Gregg, EW, Yaffe, K, Cauley, JA, Rolka, DB, Blackwell, TL, Narayan, KM, et al.Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med. 2000;160(2):174–80.CrossRefGoogle ScholarPubMed
10.Trinh, N-H, Yaffe, K.Alzheimer’s disease: incidence research and treatment. Behavioral health trends. Drug Benefit Trends. 2004;16(Suppl 5):27S–35S.Google Scholar
11.Sachdev, PS, Brodaty, H, Looi, JC.Vascular dementia: diagnosis, management and possible prevention. Med J Aust. 1999;170(2):81–5.Google Scholar
12.Stella, F, Banzato, CE, Gasparetto, Se EV, Scudeler, JL, Pacheco, JL, Kajita, RT.Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions. J Neurol Sci. 2007;257(1-2):247–9.Google Scholar
13.Wilson, PW, Kannel, WB.Obesity, diabetes, and risk of cardiovascular disease in the elderly. Am J Geriatr Cardiol. 2002;11(2):119–23,125.Google Scholar
14.Roman, GC.Vascular dementia; changing the paradigm. Curr Opin Psychiatry. 2003;16(6):635–41.Google Scholar
15.Alagiakrishnan, K, McCracken, P, Feldman, H.Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline? Postgrad Med J. 2006;82(964):101–5.CrossRefGoogle ScholarPubMed
16.Forette, F, Seux, ML, Staessen, JA, Thijs, L, Babarskiene, MR, Babeanu, S, et al.The prevention of dementia with anti-hypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162(18):2046–52.Google Scholar
17.Van Gool, WA.Can we prevent, delay, or shorten the course of dementia? PLoS Med. 2006;3(10):e430.Google Scholar
18.Brookmeyer, R, Johnson, E, Ziegler-Graham, K, Arrighi, HM.Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–91.Google Scholar
19.Thal, LJ, Carta, A, Doody, R, Leber, P, Mohs, R, Schneider, L, et al.Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord. 1997;11 Suppl 3: 46–9.Google Scholar
20.Boustani, M, Peterson, B, Hanson, L, Harris, R, Lohr, KN.Screening for dementia in primary care: a summary of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med. 2003;138(11):927–37.CrossRefGoogle ScholarPubMed
21.Forti, P, Maioli, F, Pisacane, N, Rietti, E, Montesi, F, Ravaglia, G.Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. Neurol Res. 2006;28(6):625–9.Google Scholar
22.Petersen, RC, Stevens, JC, Ganguli, M, Tangalos, EG, Cummings, JL, DeKosky, ST.Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133–42.Google Scholar
23.Borson, S, Scanlan, J, Hummel, J, Gibbs, K, Lessig, M, Zuhr, E.Implementing routine cognitive screening of older adults in primary care: process and impact on physician behavior. J Gen Intern Med. 2007;22(6):811–7.Google Scholar
24.Patterson, CJ, Gauthier, S, Bergman, H, Cohen, CA, Feightner, JW, Feldman, H, et al.The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ. 1999;160 Suppl 12:S1–15.Google Scholar
25.Nasreddine, ZS, Phillips, NA, Bedirian, V, Charbonneau, S, Whitehead, V, Collin, I, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.Google Scholar
26.Canning, SJ, Leach, L, Stuss, D, Ngo, L, Black, SE.Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Neurology. 2004;62(4):556–62.Google Scholar
27.Nutter-Upham, KE, Saykin, AJ, Rabin, LA, Roth, RM, Wishart, HA, Pare, N, et al.Verbal fluency performance in amnestic MCI and older adults with cognitive complaints. Arch Clin Neuropsychol. 2008;23(3):229–41.Google Scholar
28.Boustani, M, Callahan, CM, Unverzagt, FW, Austrom, MG, Perkins, AJ, Fultz, BA, et al.Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med. 2005;20(7):572–7.CrossRefGoogle ScholarPubMed
29.Fawcett, T.An introduction to ROC analysis. Pattern Recognition Letters. 2006;27:861–74.Google Scholar
30.Millis, S.Neuropsychology of malingering casebook: Chapter 3. London: Taylor & Francis; 2008.Google Scholar
31.Boise, L, Camicioli, R, Morgan, DL, Rose, JH, Congleton, L.Diagnosing dementia: perspectives of primary care physicians. Gerontologist. 1999;39(4):457–64.Google Scholar
32.Harvan, JR, Cotter, V.An evaluation of dementia screening in the primary care setting. J Am Acad Nurse Pract. 2006;18(8): 351–60.Google Scholar
33.Alzheimer’s Society. The Mini Mental State Examination (MMSE): a guide for people with dementia and their carers. Alzheimer’s Society Quality Research in Dementia information sheet. 2002. (Accessed 18 Jan 2007) http://www.alzheimers.org.uk/How_is_dementia_diagnosed/Diagnosis_process/info_mmse.htmGoogle Scholar
34.Ihl, R, Frolich, L, Dierks, T, Martin, EM, Maurer, K.Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res. 1992;44(2):93–106.CrossRefGoogle ScholarPubMed